Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a common psychiatric disorder in children, with worldwide prevalence of ADHD varying from 5.9 to 7.1 %, depending on the reporter. In case of inadequate response to stimulants, combination therapy of stimulants and an adjunctive medicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lachaine, Jean, Sikirica, Vanja, Mathurin, Karine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715876/
https://www.ncbi.nlm.nih.gov/pubmed/26774811
http://dx.doi.org/10.1186/s12888-016-0708-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715876/
https://www.ncbi.nlm.nih.gov/pubmed/26774811
http://dx.doi.org/10.1186/s12888-016-0708-x

Ejemplares similares